| Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin. | |
| | |
MedLine Citation:
|
PMID: 20664449 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Congenital heart block affects 2% of all mothers with anti-Ro/La antibodies, can cause heart failure in utero, and has a 20% mortality rate in the first 3 years of life. Maternal fluorinated steroids to prevent or reverse congenital heart block can cause pregnancy complications. Intravenous immunoglobulin (IVIG) has been given with maternal steroids to prevent the recurrence of congenital heart block, although its efficacy is unproven. CASE: We report the use of IVIG to prevent progression of 2:1 congenital heart block with intermittent complete heart block. After two maternal infusions of IVIG (0.4 g/kg) at 31 weeks of gestation, the fetal heart rate reverted to long periods of sinus rhythm, which was sustained until postnatal life. CONCLUSION: Our case supports investigating IVIG in the prevention or treatment of this life-threatening condition. |
| | |
Authors:
|
Anna L David; Ifat Ataullah; Rob Yates; Ian Sullivan; Peter Charles; David Williams |
Related Documents
:
|
10589059 - Prenatal diagnosis of a fetal left atrial diverticulum. 6627859 - Non-invasive fetal monitoring using radiotelemetry. 16753769 - Fetal acidemia and electronic fetal heart rate patterns: is there evidence of an associ... 19945699 - Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy m... 6353839 - Insulin-induced hypoglycemia in pregnant diabetics. maternal and fetal cardiovascular r... 9306069 - Some effects of multiple administration of detomidine during the last trimester of equi... 3309929 - Interpretation of syncytial sprouts and bridges in the human placenta. 17579229 - Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventi... 2912109 - Recurrent thromboembolism in pregnancy and puerperium. is there a need for thromboproph... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 116 Suppl 2 ISSN: 1873-233X ISO Abbreviation: Obstet Gynecol Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-28 Completed Date: 2010-08-24 Revised Date: 2011-01-06 |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 543-7 Citation Subset: AIM; IM |
Affiliation:
|
Institute for Women's Health, University College London Hospitals, London, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antibodies, Antinuclear / immunology Autoantigens / immunology Female Fetal Diseases / drug therapy*, immunology Heart Block / congenital, drug therapy*, immunology Heart Defects, Congenital Humans Immunoglobulins, Intravenous / therapeutic use* Infant, Newborn Pregnancy Pregnancy Complications / immunology* Pregnancy Outcome Ribonucleoproteins / immunology Sjogren's Syndrome / complications, immunology* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Antinuclear; 0/Autoantigens; 0/Immunoglobulins, Intravenous; 0/Ribonucleoproteins; 0/SS-A antibodies; 0/SS-B antigen |
| Comments/Corrections | |
Comment In:
|
Obstet Gynecol. 2011 Jan;117(1):177; author reply 177
[PMID:
21173668
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Murine typhus in a pregnant woman.
Next Document: Severe hydramnios and preterm delivery in association with transient maternal diabetes insipidus.